Confronto

Sincalide vs. Terlipressin

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

25126-32-3

14636-12-5

Peso molecolare

1143.29 g/mol

1227.37 g/mol

Emivita

nessun dato

Sequenza

Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2

nessun dato

Meccanismo d'azione

Sincalide

Sincalide activates CCK receptors, triggering gallbladder contraction and pancreatic enzyme secretion. This effect is used diagnostically to measure the gallbladder ejection fraction (e.g. in HIDA scintigraphy).

Terlipressin

Terlipressin is slowly converted in the body to lysine-vasopressin by cleavage of the three N-terminal glycyl residues (reservoir effect) and activates V1 receptors. The splanchnic vasoconstriction improves renal perfusion in hepatorenal syndrome.

Base di evidenze

Evidenza più alta

Studio sull'uomo

RCT sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Sincalide	Terlipressin
Germania	Non chiaro	Su prescrizione
Stati Uniti	Su prescrizione	Su prescrizione

Voci complete

Frequently asked questions

What is the difference between Sincalide and Terlipressin?: Sincalide is classified as "Ricerca (altro)", while Terlipressin is classified as "Ricerca (altro)". Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. Terlipressin: Terlipressin is a 12-amino-acid vasopressin analog and prodrug of lysine-vasopressin. As a V1 receptor agonist it is vasoconstrictive and is approved for hepatorenal syndrome (FDA 2022, Terlivaz). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Sincalide or Terlipressin?: The highest available evidence level is "Studio sull'uomo" for Sincalide and "RCT sull'uomo" for Terlipressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Sincalide and Terlipressin in Germany and the United States?: Germania: Sincalide — Non chiaro, Terlipressin — Su prescrizione. Stati Uniti: Sincalide — Su prescrizione, Terlipressin — Su prescrizione. These are factual summaries with source and review date on the individual pages.

Country

Sincalide

Terlipressin

Germania

Non chiaro

Su prescrizione

Stati Uniti

Su prescrizione

Frequently asked questions

What is the difference between Sincalide and Terlipressin?

Sincalide is classified as "Ricerca (altro)", while Terlipressin is classified as "Ricerca (altro)". Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. Terlipressin: Terlipressin is a 12-amino-acid vasopressin analog and prodrug of lysine-vasopressin. As a V1 receptor agonist it is vasoconstrictive and is approved for hepatorenal syndrome (FDA 2022, Terlivaz). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Sincalide or Terlipressin?

The highest available evidence level is "Studio sull'uomo" for Sincalide and "RCT sull'uomo" for Terlipressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Sincalide and Terlipressin in Germany and the United States?

Germania: Sincalide — Non chiaro, Terlipressin — Su prescrizione. Stati Uniti: Sincalide — Su prescrizione, Terlipressin — Su prescrizione. These are factual summaries with source and review date on the individual pages.